Bailard’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,700
| Closed | -$94K | – | 786 |
|
|
2024
Q4 | $94K | Hold |
12,700
| – | – | ﹤0.01% | 717 |
|
|
2024
Q3 | $119K | Hold |
12,700
| – | – | ﹤0.01% | 724 |
|
|
2024
Q2 | $102K | Hold |
12,700
| – | – | ﹤0.01% | 716 |
|
|
2024
Q1 | $188K | Hold |
12,700
| – | – | 0.01% | 699 |
|
|
2023
Q4 | $103K | Buy |
+12,700
| New | +$103K | ﹤0.01% | 693 |
|
|
2021
Q2 | – | Sell |
-11,700
| Closed | -$370K | – | 727 |
|
|
2021
Q1 | $370K | Hold |
11,700
| – | – | 0.01% | 453 |
|
|
2020
Q4 | $543K | Sell |
11,700
-6,000
| -34% | -$278K | 0.02% | 304 |
|
|
2020
Q3 | $583K | Sell |
17,700
-700
| -4% | -$23.1K | 0.03% | 263 |
|
|
2020
Q2 | $505K | Sell |
18,400
-48,200
| -72% | -$1.32M | 0.03% | 270 |
|
|
2020
Q1 | $1.99M | Sell |
66,600
-92,900
| -58% | -$2.78M | 0.14% | 127 |
|
|
2019
Q4 | $4.42M | Sell |
159,500
-12,900
| -7% | -$357K | 0.25% | 90 |
|
|
2019
Q3 | $3.14M | Buy |
+172,400
| New | +$3.14M | 0.19% | 113 |
|